Keto5

At Keto5, we’re on a mission to improve the quality of life for everyone. Our products dramatically increase ketone levels in the bloodstream, enabling users to achieve at least 5 times the level of ketosis achieved by diet alone. Keto5 is building a nationwide and international network of medical care professionals who will sell the products to their patients and supervise their use of the products. We are a pre-market, pre-revenue company with strategic hardware partnerships in place. We will commence building our clinical network in late Q2 of 2022.

StartEngine OWNERS Exclusive Click here to learn more

$498+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

First 30 days
First 30 days, receive 5% bonus shares




29
days

7
hours

45
mins

55
secs

$5,000+ Investment
Tier 1 Perk
Invest $5,000+ and receive 3% bonus shares

$10,000+ Investment
Tier 2 Perk
Invest $10,000+ and receive 5% bonus shares

$25,000+ Investment
Tier 3 Perk
Invest $25,000+ and receive 10% bonus shares.

$50,000+ Investment
Tier 4 Perk
Invest $50,000+ and receive 15% bonus shares

Within 5 years, even if no additional sales are achieved other than those guaranteed by Bariatrix Nutrition as per the exclusive distribution agreement for weight loss, the company will gross a minimum of $18,500,000 revenue in 2027 with a projected 60%+ gross profit. This investment is in a company dedicated to the improvement of the health of its customers.

The global ketogenic diet market size was valued at $9.57 billion in 2019. And the ketogenic diet market is set to grow by USD 1.68 billion, progressing at a CAGR of over 5.5% between 2020 and 2025.*

Nearly 1.1M physicians practice in the US of which 381,000 are in the specialties and subspecialties that treat conditions for which Keto5 products are beneficial.**